108 related articles for article (PubMed ID: 10339673)
1. Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma.
Komoike Y; Tamaki Y; Sakita I; Tomita N; Ohue M; Sekimoto M; Miyazaki M; Kadota M; Masuda N; Ooka M; Ohnishi T; Nakano Y; Kozaki T; Kobayashi T; Matsuura N; Ikeda T; Horii A; Monden M
Int J Oncol; 1999 Jun; 14(6):1157-62. PubMed ID: 10339673
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
[TBL] [Abstract][Full Text] [Related]
3. Aberrations of chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic carcinoma of the thyroid as detected by fluorescence in situ hybridisation and comparative genomic hybridisation.
Wilkens L; Benten D; Tchinda J; Brabant G; Pötter E; Dralle H; von Wasielewski R
Virchows Arch; 2000 Apr; 436(4):312-8. PubMed ID: 10834532
[TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models.
Lee JJ; Foukakis T; Hashemi J; Grimelius L; Heldin NE; Wallin G; Rudduck C; Lui WO; Höög A; Larsson C
Thyroid; 2007 Apr; 17(4):289-301. PubMed ID: 17465858
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic thyroid cancer: cytogenetic patterns by comparative genomic hybridization.
Miura D; Wada N; Chin K; Magrane GG; Wong M; Duh QY; Clark OH
Thyroid; 2003 Mar; 13(3):283-90. PubMed ID: 12729478
[TBL] [Abstract][Full Text] [Related]
6. Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sakita I; Komoike Y; Miyazaki M; Ooka M; Masuda N; Fujiwara Y; Ohnishi T; Tomita N; Sekimoto M; Ohue M; Ikeda T; Kobayashi T; Horii A; Monden M
Oncol Rep; 2000; 7(3):529-33. PubMed ID: 10767363
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
8. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.
Hunt JL; Tometsko M; LiVolsi VA; Swalsky P; Finkelstein SD; Barnes EL
Am J Surg Pathol; 2003 Dec; 27(12):1559-64. PubMed ID: 14657716
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas.
Rodrigues RF; Roque L; Rosa-Santos J; Cid O; Soares J
Br J Cancer; 2004 Jan; 90(2):492-6. PubMed ID: 14735198
[TBL] [Abstract][Full Text] [Related]
10. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide appraisal of thyroid cancer progression.
Wreesmann VB; Ghossein RA; Patel SG; Harris CP; Schnaser EA; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
Am J Pathol; 2002 Nov; 161(5):1549-56. PubMed ID: 12414503
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
[TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated and anaplastic thyroid cancer.
Patel KN; Shaha AR
Cancer Control; 2006 Apr; 13(2):119-28. PubMed ID: 16735986
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas.
Rossi ED; Straccia P; Palumbo M; Stigliano E; Revelli L; Lombardi CP; Santeusanio G; Pontecorvi A; Fadda G
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):237-41. PubMed ID: 23235344
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma.
Mizutani K; Onda M; Asaka S; Akaishi J; Miyamoto S; Yoshida A; Nagahama M; Ito K; Emi M
Cancer; 2005 May; 103(9):1785-90. PubMed ID: 15789362
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.
Santarpia L; El-Naggar AK; Cote GJ; Myers JN; Sherman SI
J Clin Endocrinol Metab; 2008 Jan; 93(1):278-84. PubMed ID: 17989125
[TBL] [Abstract][Full Text] [Related]
18. ITCH is a putative target for a novel 20q11.22 amplification detected in anaplastic thyroid carcinoma cells by array-based comparative genomic hybridization.
Ishihara T; Tsuda H; Hotta A; Kozaki K; Yoshida A; Noh JY; Ito K; Imoto I; Inazawa J
Cancer Sci; 2008 Oct; 99(10):1940-9. PubMed ID: 19016753
[TBL] [Abstract][Full Text] [Related]
19. Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.
Xu B; Ghossein R
Endocr Pathol; 2016 Sep; 27(3):205-12. PubMed ID: 27372303
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
J Cancer Res Clin Oncol; 2007 Apr; 133(4):213-8. PubMed ID: 17072649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
